# Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

> **NCT00914758** · — · UNKNOWN · sponsor: **Washington Neuropsychology Research Group** · enrollment: 1 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00914758
- **Lead sponsor:** Washington Neuropsychology Research Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2009-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914758, "Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00914758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*